Dec 4, 2025 · Library of Congress
Introduced in House
H.R. 6423
Status: In committee
HELP Copays Act
HELP Copays Act
Sponsored by Thomas H. Kean, Jr. (Republican-NJ-7)
Cosponsors
61
Actions
3
Roll calls
0
Amendments
0
Related bills
1
Actions
Dec 4, 2025 · Library of Congress
Introduced in House
Dec 4, 2025 · House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Latest activity
Lobbying reported · Biotechnology Innovation Organization · Jul 21
Biotechnology Innovation Organization reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $2,360,000
BillsH.R. 1H.R. 1492H.R. 1672H.R. 3160H.R. 3169H.R. 3269H.R. 3339H.R. 3382H.R. 3394H.R. 3521H.R. 4430H.R. 5100H.R. 5391H.R. 6423H.R. 6485H.R. 8413H.R. 9102H.R. 9142H.R. 9504S. 43S. 526S. 527S. 832S. 864S. 1041S. 1096S. 1302S. 1414S. 1546S. 1553S. 1573S. 1816S. 2658S. 2924S. 3014S. 3741S. 3788S. 3971
Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20
Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5371H.R. 6089H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.R. 9661H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 1040S. 1041S. 1071S. 1096S. 1387S. 1414S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · The ALS Association · Jul 20
The ALS Association reported 2nd Quarter (Apr 1 - June 30) lobbying for The ALS Association — $30,000
BillsH.R. 1H.R. 138H.R. 1492H.R. 1672H.R. 1685H.R. 2036H.R. 2055H.R. 2172H.R. 2491H.R. 2560H.R. 3514H.R. 3864H.R. 4016H.R. 4121H.R. 4206H.R. 5304H.R. 6001H.R. 6047H.R. 6280H.R. 6423H.R. 7336H.R. 7779H.R. 8205H.R. 8375H.R. 8490H.R. 8500H.R. 9237H.R. 9373S. 611S. 749S. 832S. 864S. 925S. 1058S. 1227S. 1261S. 1565S. 1816S. 2256S. 2572S. 2587S. 3607S. 3971S. 3988S. 4284S. 4396S. 4472S.Res. 266
Lobbying reported · American Cancer Society Cancer Action Network · Jul 20
American Cancer Society Cancer Action Network reported 2nd Quarter (Apr 1 - June 30) lobbying for American Cancer Society Cancer Action Network — $1,240,000
BillsH.R. 247H.R. 1300H.R. 1406H.R. 1834H.R. 2319H.R. 2381H.R. 2528H.R. 2571H.R. 3037H.R. 3521H.R. 4417H.R. 4425H.R. 4541H.R. 5145H.R. 5269H.R. 5439H.R. 5509H.R. 6178H.R. 6280H.R. 6423H.R. 6501H.R. 6561H.R. 6575H.R. 6845H.R. 7790H.R. 8358H.R. 8783H.R. 8839H.Res. 1196S. 864S. 1157S. 1500S. 1847S. 1866S. 2339S. 2761S. 2771S. 2903S. 2927S. 3569S. 4318S. 4440S. 4494S. 4511S. 4717
Lobbying reported · Glaxosmithkline · Jul 16
Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5509H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7391H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 891S. 1040S. 1041S. 1071S. 1096S. 1414S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
You’re all caught up.